Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × NSCLC × Radiotherapy × Clear all

Phase

Status

Recruiting 3 Not yet recruiting 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Prostatic Neoplasms 23 Breast Neoplasms 20 Glioblastoma 16 Carcinoma, Non-Small-Cell Lung 16 Sarcoma 9 Squamous Cell Carcinoma of Head and Neck 7 Rectal Neoplasms 7 Neoplasms 7 Esophageal Neoplasms 7 Brain Neoplasms 7 Uterine Cervical Neoplasms 6 Lung Neoplasms 6 Hodgkin Disease 6 Head and Neck Neoplasms 6 Glioma 6 Esophageal Squamous Cell Carcinoma 6 Pancreatic Neoplasms 5 Oropharyngeal Neoplasms 5 Melanoma 5 Colorectal Neoplasms 5 Astrocytoma 5 Triple Negative Breast Neoplasms 4 Carcinoma, Squamous Cell 4 Neoplasm Metastasis 3 Medulloblastoma 3 Lymphoma 3 Carcinoma, Intraductal, Noninfiltrating 3 Carcinoma, Hepatocellular 3 Adenocarcinoma Of Esophagus 3 Vaginal Neoplasms 2

Interventions

osimertinib 2 aflutinib 2 rezivertinib 1 pembrolizumab 1 lenvatinib 1 brigatinib 1 Tyrosine Kinase Inhibitors 1 S 1 (combination) 1 Radiotherapy 1 Pharmaceutical Preparations 1 JDQ443 1 Gefitinib 1 Chemoradiotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05089916 2026-01-14

ROSE

AIO-Studien-gGmbH

Phase 2 Active not recruiting

NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡